| Edition |
First Simon & Schuster hardcover edition. |
| Description |
x, 435 pages : illustrations ; 25 cm |
| Bibliography |
Includes bibliographical references (pages 401-416) and index. |
| Summary |
In 1989, the charismatic Joshua Boger left Merck, then America's most admired business, to found a drug company that would challenge industry giants and transform health care. Journalist Barry Werth described the company's tumultuous early days during the AIDS crisis in The Billion-Dollar Molecule, a celebrated classic of science and business journalism. Now he returns to tell the story of Vertex's bold endurance and eventual success. The pharmaceutical business is America's toughest and one of its most profitable. It's riskier and more rigorous at just about every stage than any other business, from the towering biological uncertainties inherent in its mission to treat disease; to the 30-to-1 failure rate in bringing out a successful medicine; to the multibillion-dollar cost of ramping up a successful product; to operating in the world's most regulated industry, matched only by nuclear power. Werth captures the full scope of Vertex's 25-year drive to deliver breakthrough medicines.--From publisher description. |
| Subject |
Vertex Pharmaceuticals Incorporated.
|
|
Drugs -- Marketing.
|
|
Pharmaceutical industry -- United States.
|
|
Vertex Pharmaceuticals Incorporated.
|
|
Drug Industry -- United States.
|
|
Drug Industry -- history -- United States.
|
|
History, 20th Century -- United States.
|
|
History, 21st Century -- United States.
|
|
Technology, Pharmaceutical -- United States.
|
| ISBN |
9781451655667 hardback |
|
1451655665 hardback |
|
9781451655674 (pbk.) |
|
1451655673 (pbk.) |
|
